Portal de investigación
Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
Autores de IIS La Fe
Grupos
Abstract
In non-metastatic neuroblastoma (NB), the identification of the cases that require more intensive treatment is still difficult. Minimal disease (MD) and minimal residual disease (MRD) detection in outcome prediction seems to be important in advanced neuroblastoma, but there are not many studies focused on patients with non-metastatic disease. The aim of this study was to determine whether the presence of MD detected at diagnosis could be associated with bad prognosis.
Datos de la publicación
- ISSN/ISSNe:
- 0171-5216, 1432-1335
- Tipo:
- Article
- Páginas:
- 1263-1272
- PubMed:
- 21706131
- Factor de Impacto:
- 1,166 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY SPRINGER
Citas Recibidas en Web of Science: 21
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
YÁÑEZ Y,GRAU E,OLTRA S,CAÑETE A,MARTÍNEZ F,ORELLANA C,NOGUERA R,PALANCA S,CASTEL V. Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma. J. Cancer Res. Clin. Oncol. 2011. 137. (8):p. 1263-1272. IF:2,558. (2).